← Back to Search

Medication Management Device

Experimental: Medherent Device for Mental Health Disorders

N/A

Waitlist Available

Led By Joel Feldman, JD

Research Sponsored by Terrapin Pharmacy

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change level of adherence support from enrollment/baseline compared to adherence support for the year after receiving the medherent machine (e.g. treatment)

Awards & highlights

Study Summary

This trialtests if a device helps people with mental illness take their meds correctly. Results can help people stay healthy.

Eligible Conditions

Mental Health Disorders
Medication Adherence

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change between weekly adherence from enrollment/baseline compared with weekly adherence for the year after receiving the medherent machine

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change between weekly adherence from enrollment/baseline compared with weekly adherence for the year after receiving the medherent machine

This trial's timeline: 3 weeks for screening, Varies for treatment, and change between weekly adherence from enrollment/baseline compared with weekly adherence for the year after receiving the medherent machine for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Brief Evaluation of Medication Influences and Beliefs (BEMIB) Adherence Measure

Change in Medication Records

Chart review of clinical records for change in level of adherence support

+3 more

Secondary outcome measures

Costs of Services

Psychiatric Acute Events

Trial Design

1Treatment groups

Experimental Treatment

Group I: Experimental: Medherent DeviceExperimental Treatment1 Intervention

All participants get the Medherent device. There is only one arm to this study.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkOTHER

155 Previous Clinical Trials

45,515 Total Patients Enrolled

1 Trials studying Mental Health Disorders

30 Patients Enrolled for Mental Health Disorders

University of MarylandOTHER

160 Previous Clinical Trials

302,133 Total Patients Enrolled

Terrapin PharmacyLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age limit for those included in this experiment?

"Patients must be between 18 and 80 years old to take part in this trial. Alternatively, there are 122 studies available for people under the age of 18 and 293 trials open to those above 65."

Answered by AI

Is enrollment for this investigation open at present?

"The facts presented on clinicaltrials.gov illustrate that this medical study has ceased the recruitment of participants, with its initial posting dating back to May 1st 2019 and most recent update occurring October 21st 2022. Despite no longer searching for patients, 442 other trials are currently looking for people to take part in their research."

Answered by AI

Is participation in this research accessible to me?

"To be eligible for the study, applicants must suffer from a mental health disorder and fall within the ages of 18-80. The total number of participants that this trial can accept is 150 individuals."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assessment of Medherent Medication Management Device and Adherence Platform

Joel F. Feldman 2019. "Assessment of Medherent Medication Management Device and Adherence Platform". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03775044.